The effect of azilsartan medoxomil on the variability of home blood pressure and diabetic vascular complications in patients with type 2 diabetes
Not Applicable
- Conditions
- Type 2 diabetic patients with hypertension
- Registration Number
- JPRN-UMIN000016875
- Lead Sponsor
- Tokyo Medical and Dental University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are already taking azilsartan treatment Patients with aliskiren Patients with active infectious diseases, malignant diseases, severe liver dysfunction and/or renal dysfunction Pregnant women Patients who have difficulty in understanding the protocol of the present study such as dementia or unconsciousness Patients whose anti-hypertensive agents were changed within 3 months prior to enrollment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method